Robin Jones to Sarcoma, Ewing
This is a "connection" page, showing publications Robin Jones has written about Sarcoma, Ewing.
Connection Strength
0.454
-
A Phase II multicenter, open-label, clinical and pharmokinetic trial of PM00104 in patients with advanced Ewing Family of Tumors. Invest New Drugs. 2014 Feb; 32(1):171-7.
Score: 0.454